Cited by 188Fatty Acid Research and HealthNeuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatments

Oral supplementation with docosahexaenoic acid and uridine-5’-monophosphate increases dendritic spine density in adult gerbil hippocampus

Open access
Sakamoto, Toshimasa, Cansev, Mehmet, Wurtman, Richard J.·2007·Brain Research

Abstract

Docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid, is an essential component of membrane phosphatides and has been implicated in cognitive functions. Low levels of circulating or brain DHA are associated with various neurocognitive disorders including Alzheimer's disease (AD), while laboratory animals, including animal models of AD, can exhibit improved cognitive ability with a diet enriched in DHA. Various cellular mechanisms have been proposed for DHA's behavioral effects, including increases in cellular membrane fluidity, promotion of neurite extension and inhibition of apoptosis. However, there is little direct evidence that DHA affects synaptic structure in living animals. Here we show that oral supplementation with DHA substantially increases the number of dendritic spines in adult gerbil hippocampus, particularly when animals are co-supplemented with a uridine source, uridine-5'-monophosphate (UMP), which increases brain levels of the rate-limiting phosphatide precursor CTP. The increase in dendritic spines (>30%) is accompanied by parallel increases in membrane phosphatides and in pre- and post-synaptic proteins within the hippocampus. Hence, oral DHA may promote neuronal membrane synthesis to increase the number of synapses, particularly when co-administered with UMP. Our findings provide a possible explanation for the effects of DHA on behavior and also suggest a strategy to treat cognitive disorders resulting from synapse loss.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2007.08.089

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Co-administration of uridine, docosahexaenoic acid, and choline can increase the amount of phospholipids, synaptic proteins, dendritic spine density and neurite outgrowth in rodents.

    “Several studies in rodents showed that co-administration of uridine, DHA, and choline can increase the amount of phospholipids, synaptic proteins, dendritic spine density and neurite outgrowth (Holguin et al., 2008;Sakamoto et al., 2007;Wurtman et al., 2006).”

    From The Gut-Brain Axis in Parkinson’s Disease: Possibilities for Food-Based Therapies (2017) · cites this paper as Sakamoto et al., 2007

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sakamoto, T., Cansev, M., & Wurtman, R. J.
Affiliations
  • Massachusetts Institute of Technology (US)
  • Bursa Uludağ Üni̇versi̇tesi̇ (TR)
Corresponding author
Wurtman, Richard J.
Venue
Brain Research
Publisher
Elsevier BV
Published
2007-11
Volume
1182
Pages
50-59
ISSN
0006-8993 (ISSN-L)
OpenAlex
W1997280956
Cited by
188
References
53
Citations by year
2026: 6 · 2025: 10 · 2024: 5 · 2023: 3 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 9 · 2018: 7 · 2017: 14 · 2016: 10 · 2015: 21 · 2014: 10 · 2013: 16 · 2012: 9
FWCI
8.66
Type
journal article
Language
en
Open access
Locations
  • Brain Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Bursa Uludag University - AVESIS (submittedVersion)
Funders
National Institute of Mental Health (R37MH028783, R01MH028783, MH028783)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
docosahexaenoic acid, uridine 5'-monophosphate, dendritic spine density, hippocampus, omega-3 fatty acids, synaptic structure, CTP, Alzheimer's disease, synaptic loss, gerbils, dietary supplementation
MeSH terms
Actins, Administration, Oral, Animals, Docosahexaenoic Acids, Dose-Response Relationship, Drug, Drug Interactions, Gerbillinae, Hippocampus, Male, Membrane Proteins, Models, Biological, Time Factors, Uridine Monophosphate, Glycerophospholipids, Dendritic Spines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review